Cargando…
Sorafenib-Induced Grade Four Hepatotoxicity in a Patient with Recurrent Gastrointestinal Stromal Tumor (GIST): A Case Report and Review of Literature
Gastrointestinal stromal tumor is a rare mesenchymal tumor. Sorafenib is an effective medication in these tumors based on two phase II clinical trials and a retrospective analysis. We report a rare case of a 57-year-old male with acute hepatotoxicity from sorafenib. He was treated conservatively wit...
Autores principales: | Murad, Waheed, Rabinowitz, Ian, Lee, Fa-Chyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Gastroenterology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435291/ https://www.ncbi.nlm.nih.gov/pubmed/26157843 http://dx.doi.org/10.14309/crj.2014.19 |
Ejemplares similares
-
Primary omental Gastrointestinal stromal tumor (GIST)
por: Todoroki, Takeshi, et al.
Publicado: (2007) -
LAPAROSCOPIC RESECTION OF GASTROINTESTINAL STROMAL TUMORS (GIST)
por: LOUREIRO, Marcelo de Paula, et al.
Publicado: (2016) -
Profile of patients with gastrointestinal stromal tumors
(GIST)
por: PRACUCHO, Eduardo Marcucci, et al.
Publicado: (2015) -
The radiology of gastrointestinal stromal tumours (GIST)
por: Michael King, D
Publicado: (2005) -
The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
por: Rutkowski, Piotr, et al.
Publicado: (2017)